Survey of Ophthalmology
Volume 55, Issue 3 , Pages 247-255 , May 2010

Orbital Involvement in Castleman Disease

  • Ioannis Venizelos, PhD

      Affiliations

    • Department of Pathology, Hippokration General Hospital of Thessaloniki, Thessaloniki, Greece
    • ,
  • Thomas G. Papathomas, MD

      Affiliations

    • Department of Pathology, Hippokration General Hospital of Thessaloniki, Thessaloniki, Greece
    • Corresponding Author InformationReprint address: Thomas G. Papathomas, MD, 12 Kerkiras Str. (Kalamaria), Thessaloniki, GR-55133, Greece.
    • ,
  • Maria Papathanasiou, MD

      Affiliations

    • Hematology Section, 2nd Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Hippokration General Hospital of Thessaloniki, Thessaloniki, Greece
    • ,
  • Angeliki Cheva, MD

      Affiliations

    • Department of Pathology, Hippokration General Hospital of Thessaloniki, Thessaloniki, Greece
    • ,
  • Vasilia Garypidou, PhD

      Affiliations

    • Hematology Section, 2nd Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Hippokration General Hospital of Thessaloniki, Thessaloniki, Greece
    • ,
  • Sarah Coupland, MBBS, PhD, FRCPath

      Affiliations

    • Department of Cellular and Molecular Pathology, Royal Liverpool University Hospital, Liverpool, UK

References 

  1. Alyahya GA, Prause JU, Heegaard S. Castleman's disease in the orbit. A 20-year follow-up. Acta Ophthalmol Scand. 2002;80(5):540–542
  2. Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. Br J Haematol. 2005;129(1):3–17
  3. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 1956;9(4):822–830
  4. Cheuk W, Yuen HK, Chan AC, et al. Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg Pathol. 2008;32(8):1159–1167
  5. Cheuk W, Yuen HK, Chu SY, et al. Lymphadenopathy of IgG4-related sclerosing disease. Am J Surg Pathol. 2008;32(5):671–681
  6. Coupland SE, Krause L, Delecluse HJ, et al. Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases. Ophthalmology. 1998;105(8):1430–1441
  7. Cronin DM, Warnke RA. Castleman disease: an update on classification and the spectrum of associated lesions. Adv Anat Pathol. 2009;16(4):236–246
  8. Deshpande V, Mino-Kenudson M, Brugge W, et al. Autoimmune pancreatitis: more than just a pancreatic disease? A contemporary review of its pathology. Arch Pathol Lab Med. 2005;129(9):1148–1154
  9. Ferry JA, Fung CY, Zukerberg L, et al. Lymphoma of the ocular adnexa: A study of 353 cases. Am J Surg Pathol. 2007;31(2):170–184
  10. Font RL, Croxatto JO, Rao NA. Tumors of the Eye and Ocular Adnexa. Atlas of Tumor Pathology, fourth series, fascicle 5. Washington, DC: American Registry of Pathology & Armed Forces Institute of Pathology; 2006;pp 294–297
  11. Gittinger JW. Ocular involvement in Castleman's disease. Response to radiotherapy. Ophthalmology. 1989;96(11):1646–1649
  12. Ide M, Ogawa E, Kasagi K, et al. Successful treatment of multicentric Castleman's disease with bilateral orbital tumour using rituximab. Br J Haematol. 2003;121(5):818–819
  13. Inatani M, Kashii S, Nosaka K, et al. Orbital pseudotumor as an initial manifestation of multicentric Castleman's disease. Jpn J Ophthalmol. 2005;49(6):505–508
  14. Klintworth GK, Scroggs MW. Normal eye and ocular adnexa. In:  Sternberg SS editors. Histology for Pathologists. ed 2. Philadelphia, PA: Lippincott-Raven; 1997;p. 332–335
  15. Kojima M, Nakamura S, Shimizu K, et al. Clinical implication of idiopathic plasmacytic lymphadenopathy with polyclonal hypergammaglobulinemia: a report of 16 cases. Int J Surg Pathol. 2004;12(1):25–30
  16. Kurokawa T, Suzuki S, Kawaguchi K, et al. Castleman disease presenting with ophthalmic signs and symptoms. Am J Ophthalmol. 1999;128(1):114–116
  17. Lagoo AS, Haggerty C, Kim Y, et al. Morphologic features of 115 lymphomas of the orbit and ocular adnexa categorized according to the World Health Organization classification: are marginal zone lymphomas in the orbit mucosa-associated lymphoid tissue-type lymphomas?. Arch Pathol Lab Med. 2008;132(9):1405–1416
  18. Menke DM, Chadbum A, Cesarman E, et al. Analysis of the human herpesvirus 8 (HHV-8) genome and HHV-8 vIL-6 expression in archival cases of castleman disease at low risk for HIV infection. Am J Clin Pathol. 2002;117(2):268–275
  19. Mihai S, Sitaru C. Immunopathology and molecular diagnosis of autoimmune bullous diseases. J Cell Mol Med. 2007;11(3):462–481
  20. Nishi J, Maruyama I. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node. Leuk Lymphoma. 2000;38(3–4):387–394
  21. Oh KT, Boldt HC, Danis RP. Iatrogenic central retinal vein occlusion and hyperviscosity associated with high-dose intravenous immunoglobulin administration. Am J Ophthalmol. 1997;124(3):416–418
  22. Omata T, Hamanaka T, Ikushima S, et al. Bilateral neovascular glaucoma due to multicentric Castleman disease. Jpn J Ophthalmol. 2008;52(1):70–72
  23. Park KS, Choi YJ, Song KS. Hyaline-vascular type Castleman's disease involving both orbits. Acta Ophthalmol Scand. 2002;80(5):537–539
  24. Rivas DM, Saint Blancat P, Marjou F, et al. Intra-orbital Castleman's disease. Clin Neuropathol. 2004;23(2):91–94
  25. Rosai J. Lymph nodes. In:  Rosai J,  Houston M editor. Rosai and Ackerman's Surgical Pathology. ed 9. St. Louis, MO: Mosby; 2004;p. 1905–1908
  26. Rosai J. Eye and ocular adnexa. In:  Rosai J,  Houston M editor. Rosai and Ackerman's Surgical Pathology. ed 9. St. Louis, MO: Mosby; 2004;p. 2724–2725
  27. Sato Y, Kojima M, Takata K, et al. Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease. Mod Pathol. 2009;22(4):589–599
  28. Sato Y, Ohshima K, Ichimura K, et al. Ocular adnexal IgG4-related disease has uniform clinicopathology. Pathol Int. 2008;58(8):465–470
  29. Sharara N, Holden JT, Wojno TH, et al. Ocular adnexal lymphoid proliferations: clinical, histologic, flow cytometric, and molecular analysis of forty-three cases. Ophthalmology. 2003;110(6):1245–1254
  30. Snead MP, James JN, Snead DR, et al. Orbital lymphomas and Castleman's disease. Eye. 1993;7(Pt 1):84–88
  31. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC; 2008;
  32. Tanabe N, Uchida T, Fujiwara Y, et al. Successful treatment of idiopathic plasmacytic lymphadenopathy with polyclonal hypergammaglobulinemia. Intern Med. 1992;31(4):549–552

 The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article.

PII: S0039-6257(09)00262-8

doi: 10.1016/j.survophthal.2009.09.003

Survey of Ophthalmology
Volume 55, Issue 3 , Pages 247-255 , May 2010

Article Tools

* Image Usage & Resolution